A woman in white lab coat holding up a tube.

WHO WE ARE

Optimize the Value of your Biopharmaceutical Assets

At Biopharm Capital and Consulting (BCC), we partner with drug development companies and investors to help create drug development strategies and solutions that maximize value to your asset, your investors, and the patients you serve.

OUR MISSION & FOCUS

Our Mission

Provide top-tier advisory/consulting expertise in developing clinical assets and securing the required capital with strategies that are aligned with your corporate goals, investor requirements, and market demands.

A group of people sitting around a table.

Who We Serve

A group of people in lab coats and goggles.

Emerging Biotechnology Companies

We offer emerging biotech companies customized clinical strategy, operational delivery, and capital support to accelerate asset development and value creation.

A person holding a test tube in front of some chemical ingredients.

Mid-Cap and Large Pharma

We provide mid-cap and large pharma companies a flexible, low-resource virtual development model for asset management including US market authorization and label expansion. Our services optimize your pipeline, allowing you to focus on core priorities while maximizing asset value.

A group of people shaking hands in an office.

Venture Capital and Investment Sector Support

We provide investors with objective insights into the clinical development strategy, focusing on critical value inflection points, opportunities to mitigate risk, or a “fail fast / fail cheap” approach. Most importantly, we help manage the efficient and effective operational delivery of the invested asset.